{
    "organizations": [],
    "uuid": "315e83776ff9668227ca6ee088025f0b6b51cac9",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cti-biopharma-prices-underwritten/brief-cti-biopharma-prices-underwritten-public-offering-of-60-million-of-common-stock-idUSASB0C50S",
    "ord_in_thread": 0,
    "title": "BRIEF-CTI BioPharma Prices Underwritten Public Offering Of $60 Million Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 9 (Reuters) - CTI BioPharma Corp:\n* CTI BIOPHARMA PRICES UNDERWRITTEN PUBLIC OFFERING OF $60 MILLION OF COMMON STOCK\n* CTI BIOPHARMA CORP - ‍PRICING OF PUBLIC OFFERING OF 20 MILLION SHARES OF ITS COMMON STOCK, AT A PUBLIC OFFERING PRICE OF $3.00 PER SHARE OF COMMON STOCK​ Source text for Eikon:\n ",
    "published": "2018-02-09T20:12:00.000+02:00",
    "crawled": "2018-02-10T14:21:45.031+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cti",
        "biopharma",
        "corp",
        "cti",
        "biopharma",
        "price",
        "underwritten",
        "public",
        "offering",
        "million",
        "common",
        "stock",
        "cti",
        "biopharma",
        "corp",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "public",
        "offering",
        "price",
        "per",
        "share",
        "common",
        "source",
        "text",
        "eikon"
    ]
}